Zynex Inc
NASDAQ:ZYXI
Net Margin
Zynex Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Zynex Inc
NASDAQ:ZYXI
|
68.4m USD |
2%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
225.3B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.2B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
139.7B USD |
11%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
132.6B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.6B USD |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58B USD |
8%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
50.1B EUR |
9%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
42B USD |
77%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
268.7B CNY |
33%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
33.3B USD |
23%
|
Zynex Inc
Glance View
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 774 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current (IFC), neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS). The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, and E-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream, Knee Braces and LSO Back Braces, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter. CM-1500 is a Zynex fluid monitoring system.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Zynex Inc's most recent financial statements, the company has Net Margin of 1.6%.
You don't have any saved screeners yet